Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Periodontology 2000|December 19, 2019
Periodontal therapeutics: Current host-modulation agents and future directionsLorne M Golub, Hsi-Ming Lee
Pharmacological Research|June 10, 2011
Chemically modified tetracycline-3 (CMT-3): a novel inhibitor of the serine proteinase, elastaseYing Gu, Hsi-Ming Lee, Sanford R Simon, et al.
Frontiers in Clinical Diabetes and Healthcare|March 18, 2025
Diabetes, periodontal disease, and novel therapeutic approaches- host modulation therapyYing Gu, Lorne M Golub, Hsi-Ming Lee, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3Yu Liu, George Tortora, Maria E Ryan, et al.
FEMS Immunology and Medical Microbiology|November 14, 2009
Doxycycline [corrected] inhibits mononuclear cell-mediated connective tissue breakdownYing Gu, Hsi-Ming Lee, Timo Sorsa, et al.
Annals of Medicine|October 6, 2005
Inhibition of breast cancer cell extracellular matrix degradative activity by chemically modified tetracyclinesYing Gu, Hsi-Ming Lee, Lorne M Golub, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 14, 2004
Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trialDavid L Brown, Kavita K Desai, Babak A Vakili, et al.
Pageof 8